enVVeno Medical Corporation— Sankey Diagram
Quarterly mode · period ending 2022-12-31 · SEC EDGAR
ComparingFY2022 (Q4) vs FY2021 (Q4)
Revenue
$147K
↑+2947.3% +$142Kvs FY2021 (Q4)
Gross Profit
$147K
↑+2947.3% +$142Kvs FY2021 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2022 (Q4) | FY2021 (Q4) |
|---|---|---|
| Revenue | $147K | $5K |
| COGS | $0 | $0 |
| Gross Profit | $147K | $5K |
| R&D | $3M | $2M |
| SG&A | $4M | $7M |
| D&A | $54K | $46K |
| Other OpEx | $0 | $0 |
| Operating Income | $0 | $0 |
| Interest Exp. | $0 | $0 |
| Other Non-Op | $0 | $0 |
| Pretax Income | $0 | $0 |
| Tax | $0 | $0 |
| Net Income | $0 | $0 |
QuarterCharts · SEC EDGAR data · NVNO · Comparing FY2022 (Q4) vs FY2021 (Q4)